Wave Life Sciences Ltd (WVE) Stock Price & News - Google Finance (2024)

FAQs

What is the price target for wave life sciences? ›

The average price target for Wave Life Sciences is $12.20. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $19.00 ,the lowest forecast is $5.00.

Market cap: $0.75 Billion

As of May 2024 Wave Life Sciences has a market cap of $0.75 Billion. This makes Wave Life Sciences the world's 5519th most valuable company by market cap according to our data.

The stock symbol for Lifewav-M is "LIFE."

At Wave, we are focused on unlocking the broad potential of RNA medicines to transform human health. To do this, we are leveraging a toolkit of RNA-targeting modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders.

WAVD stock recorded 13/30 (43%) green days with 21.80% price volatility over the last 30 days. Based on the WaveDancer, Inc. stock forecast, it's now a good time to buy WAVD stock because it's trading 18.78% below our forecast, and it could be undervalued.

Dr. Paul Bolno has served as President and CEO of Wave since 2013 and oversaw the company's initial public offering in 2015.

When did Wave Life Sciences go public? Wave Life Sciences initial public offering (IPO) occurred on November 11, 2015.

Wave Life Sciences Begins Public Offering Of $100 Mln Of Shares; Stock Down Over 21% | Nasdaq.

Sand Hill Angels and Sand Hill Angels are the most recent investors.

What kind of company is LifeWave? ›

Driven by innovation and proven by science, LifeWave is a breakthrough patented health technology company dedicated to honoring the light of life and harnessing the body's natural energy to reverse aging and maximize human potential, while holding true to its values of high product standards, leading with service, ...

LifeWave, founded in 2004, has grown to over 275 employees with offices in the U.S., Ireland, Japan, Taiwan, Philippines, and Malaysia with numerous distribution centers across the world.

GSK-5462688 is under development for the treatment of alpha-1 antitrypsin deficiency. It acts by targeting alpha-1 antiproteinase (SERPINA-1). It is administered through subcutaneous route. The drug candidate is being developed based on the adenosine deaminases mediated RNA editing (ADAR editing) technology.

Waves do work when they move objects. We can see this work when heavy logs move across ocean basins or sand is transported. Work can also be converted into sound energy heard when waves crash on the shore. The powerful energy in waves can also be used to do work by moving generator parts to produce electricity.

You don't control the wave or know how it will turn out, you just have to navigate it moment to moment. If we can learn to ride the rolling uncertainty of our lives like a wave, staying open each moment to what unfolds, we can live without as much stress and anxiety, and just be present to what is happening.

A target price is an estimate of the future price of a stock. Target prices are based on earnings forecasts and assumed valuation multiples.

Daily Waves (WAVES) Price Prediction For Today, Tomorrow, this Week, and Next 30 Days. Based on your price prediction input for Waves, the value of WAVES is projected to increase by 5%, potentially reaching $ 2.445544 in the next 30 days.

Sono Group N.V. Stock Prediction 2025

The Sono Group N.V. stock prediction for 2025 is currently $ 0.099631, assuming that Sono Group N.V. shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a -51.87% increase in the SEV stock price.